159 related articles for article (PubMed ID: 15853681)
21. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.
Wang KC; Kim JA; Sivasankaran R; Segal R; He Z
Nature; 2002 Nov; 420(6911):74-8. PubMed ID: 12422217
[TBL] [Abstract][Full Text] [Related]
22. PirB is a novel potential therapeutic target for enhancing axonal regeneration and synaptic plasticity following CNS injury in mammals.
Gou Z; Mi Y; Jiang F; Deng B; Yang J; Gou X
J Drug Target; 2014 Jun; 22(5):365-71. PubMed ID: 24405091
[TBL] [Abstract][Full Text] [Related]
23. Soluble myelin-associated glycoprotein (MAG) found in vivo inhibits axonal regeneration.
Tang S; Woodhall RW; Shen YJ; deBellard ME; Saffell JL; Doherty P; Walsh FS; Filbin MT
Mol Cell Neurosci; 1997; 9(5-6):333-46. PubMed ID: 9361272
[TBL] [Abstract][Full Text] [Related]
24. Nogo-A-deficient mice reveal strain-dependent differences in axonal regeneration.
Dimou L; Schnell L; Montani L; Duncan C; Simonen M; Schneider R; Liebscher T; Gullo M; Schwab ME
J Neurosci; 2006 May; 26(21):5591-603. PubMed ID: 16723516
[TBL] [Abstract][Full Text] [Related]
25. Nogo-A, a potent inhibitor of neurite outgrowth and regeneration.
Huber AB; Schwab ME
Biol Chem; 2000; 381(5-6):407-19. PubMed ID: 10937871
[TBL] [Abstract][Full Text] [Related]
26. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth.
McKerracher L; David S; Jackson DL; Kottis V; Dunn RJ; Braun PE
Neuron; 1994 Oct; 13(4):805-11. PubMed ID: 7524558
[TBL] [Abstract][Full Text] [Related]
27. Resistance of interleukin-6 to the extracellular inhibitory environment promotes axonal regeneration and functional recovery following spinal cord injury.
Yang G; Tang WY
Int J Mol Med; 2017 Feb; 39(2):437-445. PubMed ID: 28075461
[TBL] [Abstract][Full Text] [Related]
28. Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth.
Benson MD; Romero MI; Lush ME; Lu QR; Henkemeyer M; Parada LF
Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10694-9. PubMed ID: 16020529
[TBL] [Abstract][Full Text] [Related]
29. NI-35/250/nogo-a: a neurite growth inhibitor restricting structural plasticity and regeneration of nerve fibers in the adult vertebrate CNS.
Bandtlow CE; Schwab ME
Glia; 2000 Jan; 29(2):175-81. PubMed ID: 10625336
[No Abstract] [Full Text] [Related]
30. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor.
Liu BP; Fournier A; GrandPré T; Strittmatter SM
Science; 2002 Aug; 297(5584):1190-3. PubMed ID: 12089450
[TBL] [Abstract][Full Text] [Related]
31. TACE-induced cleavage of NgR and p75NTR in dorsal root ganglion cultures disinhibits outgrowth and promotes branching of neurites in the presence of inhibitory CNS myelin.
Ahmed Z; Mazibrada G; Seabright RJ; Dent RG; Berry M; Logan A
FASEB J; 2006 Sep; 20(11):1939-41. PubMed ID: 16849393
[TBL] [Abstract][Full Text] [Related]
32. Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions.
Thallmair M; Metz GA; Z'Graggen WJ; Raineteau O; Kartje GL; Schwab ME
Nat Neurosci; 1998 Jun; 1(2):124-31. PubMed ID: 10195127
[TBL] [Abstract][Full Text] [Related]
33. Lentiviral mediated expression of a NGF-soluble Nogo receptor 1 fusion protein promotes axonal regeneration.
Zhang Y; Gao F; Wu D; Moshayedi P; Zhang X; Ellamushi H; Yeh J; Priestley JV; Bo X
Neurobiol Dis; 2013 Oct; 58():270-80. PubMed ID: 23811498
[TBL] [Abstract][Full Text] [Related]
34. Nogo: a molecular determinant of axonal growth and regeneration.
Grandpré T; Strittmatter SM
Neuroscientist; 2001 Oct; 7(5):377-86. PubMed ID: 11597097
[TBL] [Abstract][Full Text] [Related]
35. The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats.
Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Zeng L; Long ZY; Wu YM
Biomaterials; 2011 Nov; 32(31):7988-98. PubMed ID: 21784510
[TBL] [Abstract][Full Text] [Related]
36. Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A.
Weinmann O; Schnell L; Ghosh A; Montani L; Wiessner C; Wannier T; Rouiller E; Mir A; Schwab ME
Mol Cell Neurosci; 2006; 32(1-2):161-73. PubMed ID: 16697217
[TBL] [Abstract][Full Text] [Related]
37. RGMa inhibition promotes axonal growth and recovery after spinal cord injury.
Hata K; Fujitani M; Yasuda Y; Doya H; Saito T; Yamagishi S; Mueller BK; Yamashita T
J Cell Biol; 2006 Apr; 173(1):47-58. PubMed ID: 16585268
[TBL] [Abstract][Full Text] [Related]
38. Myelin-associated glycoprotein inhibits axonal regeneration from a variety of neurons via interaction with a sialoglycoprotein.
DeBellard ME; Tang S; Mukhopadhyay G; Shen YJ; Filbin MT
Mol Cell Neurosci; 1996 Feb; 7(2):89-101. PubMed ID: 8731478
[TBL] [Abstract][Full Text] [Related]
39. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z
Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310
[TBL] [Abstract][Full Text] [Related]
40. Rho-ROCK inhibitors as emerging strategies to promote nerve regeneration.
Kubo T; Hata K; Yamaguchi A; Yamashita T
Curr Pharm Des; 2007; 13(24):2493-9. PubMed ID: 17692017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
